Transmission electron microscopic morphological study and flow cytometric viability assessment of Acinetobacter baumannii susceptible to Musca domestica cecropin
- PMID: 24883421
- PMCID: PMC4032720
- DOI: 10.1155/2014/657536
Transmission electron microscopic morphological study and flow cytometric viability assessment of Acinetobacter baumannii susceptible to Musca domestica cecropin
Abstract
Multidrug-resistant (MDR) Acinetobacter baumannii infections are difficult to treat owing to the extremely limited armamentarium. Expectations about antimicrobial peptides' use as new powerful antibacterial agents have been raised on the basis of their unique mechanism of action. Musca domestica cecropin (Mdc), a novel antimicrobial peptide from the larvae of Housefly (Musca domestica), has potently active against Gram-positive and Gram-negative bacteria standard strain. Here we evaluated the antibacterial activity of Mdc against clinical isolates of MDR-A. baumannii and elucidate the related antibacterial mechanisms. The minimal inhibitory concentration (MIC) of Mdc was 4 μg/mL. Bactericidal kinetics of Mdc revealed rapid killing of A. baumannii (30 min). Flow cytometry using viability stain demonstrated that Mdc causes A. baumannii membrane permeabilization in a concentration- and time-dependent process, which correlates with the bactericidal action. Moreover, transmission electron microscopic (TEM) examination showed that Mdc is capable of disrupting the membrane of bacterial cells, resulting in efflux of essential cytoplasmic components. Overall, Mdc could be a promising antibacterial agent for MDR-A. baumannii infections.
Figures




Similar articles
-
Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli.Appl Microbiol Biotechnol. 2012 Aug;95(4):939-45. doi: 10.1007/s00253-011-3793-2. Epub 2011 Dec 28. Appl Microbiol Biotechnol. 2012. PMID: 22202966
-
Antimicrobial functional divergence of the cecropin antibacterial peptide gene family in Musca domestica.Parasit Vectors. 2019 Nov 14;12(1):537. doi: 10.1186/s13071-019-3793-0. Parasit Vectors. 2019. PMID: 31727142 Free PMC article.
-
Novel circular antimicrobial peptides to combat a critical listed bacterial pathogen multi drug resistant Acinetobacter baumannii.Microb Pathog. 2025 Jun;203:107448. doi: 10.1016/j.micpath.2025.107448. Epub 2025 Mar 4. Microb Pathog. 2025. PMID: 40049251
-
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.Microb Pathog. 2020 Sep;146:104238. doi: 10.1016/j.micpath.2020.104238. Epub 2020 May 5. Microb Pathog. 2020. PMID: 32387392 Review.
-
A Review of the Antimicrobial Potential of Musca domestica as a Natural Approach with Promising Prospects to Countermeasure Antibiotic Resistance.Vet Med Int. 2022 Dec 30;2022:9346791. doi: 10.1155/2022/9346791. eCollection 2022. Vet Med Int. 2022. PMID: 36619234 Free PMC article. Review.
Cited by
-
Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.Infect Drug Resist. 2019 Aug 5;12:2417-2428. doi: 10.2147/IDR.S214057. eCollection 2019. Infect Drug Resist. 2019. PMID: 31496754 Free PMC article.
-
An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections.Pharmaceuticals (Basel). 2023 Sep 11;16(9):1281. doi: 10.3390/ph16091281. Pharmaceuticals (Basel). 2023. PMID: 37765087 Free PMC article. Review.
-
Green synthesis of chitosan nanoparticles, optimization, characterization and antibacterial efficacy against multi drug resistant biofilm-forming Acinetobacter baumannii.Sci Rep. 2022 Nov 18;12(1):19869. doi: 10.1038/s41598-022-24303-5. Sci Rep. 2022. PMID: 36400832 Free PMC article.
-
Molecular mechanism of antimicrobial activity of chlorhexidine against carbapenem-resistant Acinetobacter baumannii.PLoS One. 2019 Oct 29;14(10):e0224107. doi: 10.1371/journal.pone.0224107. eCollection 2019. PLoS One. 2019. PMID: 31661500 Free PMC article.
-
Designing of a novel chimeric antimicrobial peptide against Acinetobacter baumannii using three different bioinformatics methods and evaluation of its antimicrobial activity in vitro.Res Pharm Sci. 2025 Mar 31;20(2):268-291. doi: 10.4103/RPS.RPS_70_23. eCollection 2025 Apr. Res Pharm Sci. 2025. PMID: 40444158 Free PMC article.
References
-
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii . Nature Reviews Microbiology. 2007;5(12):939–951. - PubMed
-
- Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Review of Anti-Infective Therapy. 2013;11(4):395–409. - PubMed
-
- Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. International Journal of Antimicrobial Agents. 2011;37(2):102–109. - PubMed
-
- Bourigault C, Corvec S, Bretonniere C, et al. Investigation and management of multidrug-resistant Acinetobacter baumannii spread in a French medical intensive care unit: one outbreak may hide another. American Journal of Infection Control. 2012;41(7):652–653. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical